|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits with banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits with banks | ||||||||||||||||||||
| Debt securities available-for-sale, at fair value | ||||||||||||||||||||
| Debt securities held-to-maturity (fair value of $408,474 at 2026 and $426,799 at 2025) | ||||||||||||||||||||
| Equity securities with readily determinable fair value | ||||||||||||||||||||
| Equity securities with no readily determinable fair value | ||||||||||||||||||||
| Restricted stock, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, before allowance for credit losses | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans, net of allowance for credit losses | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Bank premises held for sale | ||||||||||||||||||||
| Foreclosed assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Intangible assets held for sale | ||||||||||||||||||||
| Mortgage servicing rights, at fair value | ||||||||||||||||||||
| Investments in unconsolidated subsidiaries | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Junior subordinated debentures issued to capital trusts | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 25,000,000 shares authorized; none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value; 125,000,000 shares authorized; shares issued of 38,451,113 at 2026 and 32,899,104 at 2025; shares outstanding of 36,365,612 at 2026 and 31,431,924 at 2025 | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock at cost, 2,085,501 shares at 2026 and 1,467,180 at 2025 | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
